Enterococcal bacteremia in children: Clinical Significance of vancomycin resistance

被引:0
|
作者
Jo, Kyo Jin [1 ]
Lee, Hyeon Seo [2 ]
Lee, Narae [1 ]
Byun, Shin Yun [1 ]
Chang, Chulhun [3 ]
Park, Su Eun [1 ]
机构
[1] Pusan Natl Univ, Yangsan Hosp, Sch Med, Dept Pediat, Yangsan, South Korea
[2] Pusan Natl Univ, Off Infect Control, Yangsan Hosp, Yangsan, South Korea
[3] Pusan Natl Univ, Sch Med, Dept Lab Med, Yangsan, South Korea
来源
PEDIATRICS AND NEONATOLOGY | 2025年 / 66卷 / 02期
关键词
Bacteremia; Children; Enterococcus; Vancomycin-resistant enterococci; BLOOD-STREAM INFECTIONS; RISK-FACTORS; EPIDEMIOLOGY;
D O I
10.1016/j.pedneo.2024.01.007
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background: We aimed to describe the clinical and microbiological characteristics of enterococcal bacteremia, as well as the effect of Enterococcus resistance against vancomycin on clinical outcomes in Korean children. Methods: We retrospectively reviewed the medical records of children diagnosed with enterococci isolated from blood cultures at Pusan National University Children's Hospital between December 2009 and November 2021. Results: In total, 64 patients were enrolled in the study. The median age was 0 years (range 0-15), and 43 (67.2%) patients were male. Enterococcus faecalis (50%) was the most commonly identified bacterial strain. Significant underlying diseases were present in 60 patients (93.8%), and the source of bacteremia was identified in 36 patients (56.3%). Among these, intravascular device was the most common identifiable source. Fifty-six (87.5%) patients had previously received broad-spectrum antibiotics and 54 (84.4%) patients were nosocomial in origin. Twenty-nine (45.3%) strains were resistant to ampicillin, and 16 (25%) strains were resistant to vancomycin. All patients with vancomycin-resistant enterococci (VRE) had underlying disease (P = 0.199), and focus of bacteremia was significantly more frequent in VRE patients (P = 0.014). Of all the patients, after appropriate antibiotic treatment, five (7.8%) patients had recurrent enterococcal bacteremia, and seven (10.9%) patients were diagnosed with bacteremia, defined as other pathogens from blood culture. The 30-day mortality rate was 7.8%. Conclusion: Enterococcal bacteremia in children is usually nosocomial and occurs in children with serious underlying diseases. Because the number of enrolled patients and mortality were small in our study, it is difficult to identify whether the factor that determines prognosis in patients with enterococcal bacteremia is VRE or an underlying disease. Further studies with a large number of patients in a specific group are needed.
引用
收藏
页码:142 / 146
页数:5
相关论文
共 50 条
  • [31] Vancomycin-resistant enterococcal bacteremia in a hematology unit: Molecular epidemiology and analysis of clinical course
    Yoo, JH
    Lee, DG
    Choi, SM
    Choi, JH
    Shin, WS
    Kim, M
    Yong, DG
    Lee, KW
    Min, WS
    Kim, CC
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2005, 20 (02) : 169 - 176
  • [32] Comparison of linezolid and daptomycin for the treatment of vancomycin-resistant enterococcal bacteremia
    Narayanan, Navaneeth
    Rai, Rena
    Vaidya, Parth
    Desai, Avani
    Bhowmick, Tanaya
    Weinstein, Melvin P.
    THERAPEUTIC ADVANCES IN INFECTIOUS DISEASE, 2019, 6
  • [33] Vancomycin-resistant enterococcal bacteremia and necrotizing enterocolitis in a preterm neonate
    Raskind, CH
    Dembry, LM
    Gallagher, PG
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2005, 24 (10) : 943 - 944
  • [34] Treatment of vancomycin-resistant enterococcal bacteremia using combination therapy
    Dominguez, ER
    Diaz, A
    Greene, JN
    Sandin, RL
    INFECTIONS IN MEDICINE, 1999, 16 (04) : 291 - 293
  • [35] Risk factors and outcomes associated with persistent vancomycin resistant Enterococcal Bacteremia
    Emily Fox
    David Ha
    Mark Bounthavong
    Lina Meng
    Emily Mui
    Marisa Holubar
    Stanley Deresinski
    William Alegria
    BMC Infectious Diseases, 22
  • [36] Risk factors and outcomes associated with persistent vancomycin resistant Enterococcal Bacteremia
    Fox, Emily
    Ha, David
    Bounthavong, Mark
    Meng, Lina
    Mui, Emily
    Holubar, Marisa
    Deresinski, Stanley
    Alegria, William
    BMC INFECTIOUS DISEASES, 2022, 22 (01)
  • [37] Vancomycin-resistant enterococcal bacteremia: Natural history and attributable mortality
    Edmond, MB
    Ober, JF
    Dawson, JD
    Weinbaum, DL
    Wenzel, RP
    CLINICAL INFECTIOUS DISEASES, 1996, 23 (06) : 1234 - 1239
  • [38] Active surveillance reduces the incidence of vancomycin-resistant enterococcal bacteremia
    Price, CS
    Paule, S
    Noskin, GA
    Peterson, LR
    CLINICAL INFECTIOUS DISEASES, 2003, 37 (07) : 921 - 928
  • [39] Vancomycin-resistant and vancomycin-sensitive enterococcal bacteremia: Effect on patient outcomes.
    Wittbrodt, ET
    Cawley, MJ
    Eapen, T
    CRITICAL CARE MEDICINE, 1999, 27 (01) : A86 - A86
  • [40] ENTEROCOCCAL BACTEREMIA - CLINICAL IMPLICATIONS AND DETERMINANTS OF DEATH
    GARRISON, RN
    FRY, DE
    BERBERICH, S
    POLK, HC
    ANNALS OF SURGERY, 1982, 196 (01) : 43 - 47